unity3dblockchain|2024年3月:医药生物原料药价格走势解析,三药品同比波动显著

Date: 5个月前 (04-12)View: 57Comments: 0

Hexun brings you the latest highlights of securities firms for your reference.Unity3dblockchain:

Price trends of raw materials in the pharmaceutical and biological industry in March 2024, the prices of hormone-based raw materials remained stable, with the prices of three kinds of drugs such as progesterone falling compared with the same period last year, while the prices of three kinds of drugs, such as diosgenin, rose year-on-year. The prices of antibiotic intermediates are also stable, but the prices of some drugs have increased or decreased compared with the same period last year. The prices of most β-lactam antibiotics remained unchanged, while the prices of a few drugs decreased compared with the same period last year. The price of cardiovascular raw materials fluctuated slightly and changed to varying degrees compared with the same period last year.

unity3dblockchain|2024年3月:医药生物原料药价格走势解析,三药品同比波动显著

Risk tips should pay attention to the possible risks such as price fluctuations, industry competition and policy changes.

Disclaimer the content of this article is for reference only and does not represent the position of Hexun. Investors need to operate cautiously and at their own risk.

Hexun self-selected Stock Writer risk Tip: the above content is only the views of the author or guest, does not represent any position of Hexun, and does not constitute any investment advice related to Hexun. Before making any investment decision, investors should consider the risk factors related to investment products according to their own circumstances and consult professional investment advisers if necessary. Hexun tries its best but cannot confirm the authenticity, accuracy and originality of the above content, and Hexun does not make any guarantee or commitment.

Tags:

Prev: bigcryptogames| Afternoon review: coke rose by more than 4%, urea rose by more than 3%
Next: newcryptogamescomingout|方正证券:储能系统经济性不断提升 大储、工商储显著受益

Related articlesNo more
︿